The European Gazette
SEE OTHER BRANDS

The latest news from Europe

The European Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.

Press releases published on April 23, 2025

WISeKey Expands Implementation of Digital Identity Solutions from Seychelles to Africa: Empowering Nations with Secure National ID Systems

WISeKey Expands Implementation of Digital Identity Solutions from Seychelles to Africa: Empowering Nations with Secure National ID Systems

WISeKey Expands Implementation of Digital Identity Solutions from Seychelles to Africa: Empowering Nations with Secure National ID Systems Geneva, Switzerland – April 23, 2025 — WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a …

Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting

Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting

CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …

Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-Cel at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-Cel at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …

Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting

Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting

MANNHEIM, Germany, April 23, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced an abstract on …

Riyadh Air Sets High Safety Standards for Pilot Training by Selecting CEFA Aviation’s FAS

Riyadh Air Sets High Safety Standards for Pilot Training by Selecting CEFA Aviation’s FAS

COLMAR, FRANCE, April 23, 2025 /⁨EINPresswire.com⁩/ -- Riyadh Air, Saudi Arabia’s premier new flag carrier, has selected CEFA Aviation, a leading provider of flight data animation solutions, to provide its CEFA FAS (Flight Animation System) software to …

Immatics Announces Upcoming Oral and Poster Presentation on IMA203 TCR T-cell Therapy at 2025 ASCO Annual Meeting

Immatics Announces Upcoming Oral and Poster Presentation on IMA203 TCR T-cell Therapy at 2025 ASCO Annual Meeting

Houston, Texas and Tuebingen, Germany, April 23, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today …

Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting

Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting

- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC interim clinical data selected for poster presentation - Conference call on Thursday, May 22 at 5:30 p.m. ET to discuss full ASCO® data set UTRECHT, The Netherlands and CAMBRIDGE, Mass …

Holding(s) in Company

Holding(s) in Company

The Board of Serabi announces that the Company has received the following TR-1 notification which is set out below. Serabi Gold plc   Michael Hodgson Tel: +44 (0)20 7246 6830 Chief Executive Mobile: +44 (0)7799 473621     Andrew Khov            Vice …

Caro Holdings Launches AI Chat Agent Platform to Revolutionize Customer Service and Boost Business Efficiency

Caro Holdings Launches AI Chat Agent Platform to Revolutionize Customer Service and Boost Business Efficiency

SHEFFIELD, United Kingdom, April 23, 2025 (GLOBE NEWSWIRE) -- Caro Holdings announces the release of its new AI Chat Agent platform - an intelligent, always-on assistant team built to help businesses save time, cut costs, and deliver top-tier customer …

FXBO and FiveComply Join Forces to Elevate Broker Solutions

FXBO and FiveComply Join Forces to Elevate Broker Solutions

CYPRUS, April 23, 2025 /⁨Business News⁩/ -- FXBO and FiveComply have announced a new strategic partnership designed to deliver superior support to brokers operating within today’s complex financial services landscape. By uniting FXBO’s advanced back-office …

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

FDA recently granted Breakthrough Device Designation to AVIM therapy for use in patients with uncontrolled hypertension at increased cardiovascular risk HRS Satellite Symposium will feature leading experts in electrophysiology, hypertension management and …

Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery

Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery

Press release – No. 5 / 2025 Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery Utpal joins Zealand Pharma at a pivotal moment as it aims to become a leader in the management of obesity …

Nokia cancels repurchased shares 

Nokia cancels repurchased shares 

Nokia Corporation Stock Exchange Release 23 April 2025 at 16:00 EEST Nokia cancels repurchased shares  Nokia Corporation has today cancelled 150 000 000 Nokia shares held by the company in line with the decision by the Board of Directors. The shares were …

Nokia mitätöi takaisinostettuja osakkeita

Nokia mitätöi takaisinostettuja osakkeita

Nokia Oyj Pörssitiedote 23.4.2025 klo 16.00 Nokia mitätöi takaisinostettuja osakkeita  Nokia Oyj on tänään mitätöinyt 150 000 000 yhtiön hallussa olevaa Nokian osaketta hallituksen tekemän päätöksen mukaisesti. Osakkeet hankittiin marraskuussa 2024 …

NEVADA CANYON ANNOUNCES SIGNIFICANT RESULTS FROM INITIAL EXPLORATION PROGRAM ON THE AGAI PAH PROPERTY

NEVADA CANYON ANNOUNCES SIGNIFICANT RESULTS FROM INITIAL EXPLORATION PROGRAM ON THE AGAI PAH PROPERTY

Reno, Nevada, April 23, 2025 (GLOBE NEWSWIRE) -- Canyon Gold Corp. (OTCQX Markets: NGLD) (The “Company” or “Nevada Canyon”) is pleased to announce results from the initial Phase I exploration program on one of the Company’s Accelerator properties, the Agai …

Icon Energy Corp. Reports Financial Results for the Year Ended December 31, 2024, and Declares Cash Dividend of $0.07 per Common Share

Icon Energy Corp. Reports Financial Results for the Year Ended December 31, 2024, and Declares Cash Dividend of $0.07 per Common Share

ATHENS, Greece, April 23, 2025 (GLOBE NEWSWIRE) -- Icon Energy Corp. (“Icon” or the “Company”) (Nasdaq: ICON), an international shipping company that provides worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing …

Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference

Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference

SARASOTA, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing novel intranasal therapies for concussion and brain-related conditions, today announced its participation in the 15th Annual …

Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine”

Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine”

Joint meeting to be held in Las Vegas, May 14-17 Presentation will be delivered by Dr. Alessandro Villa of Miami Cancer Institute Topline study results demonstrate clinically meaningful improvements in OLP Visible lesion resolution during treatment; return …

Bluejay Therapeutics Announces Upcoming Presentation of Preclinical Data in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at European Association for the Study of the Liver (EASL) Congress 2025

Bluejay Therapeutics Announces Upcoming Presentation of Preclinical Data in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at European Association for the Study of the Liver (EASL) Congress 2025

REDWOOD CITY, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases, today announced it will present …

Enlivex Therapeutics to Showcase Allocetra’s Potential in Osteoarthritis at OARSI 2025 World Congress

Enlivex Therapeutics to Showcase Allocetra’s Potential in Osteoarthritis at OARSI 2025 World Congress

Presentations to underscore AllocetraTM’s novel mechanism targeting immune imbalance in joint disease Ness-Ziona, Israel, April 23, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service